Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bianju Niaoyan Granules for Lower Urinary Tract Infection
CTR20160351Phase 2Active
- Sponsor
- Zhuzhou Qianjin Pharmaceutical Co., Ltd.
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Bianju Niaoyan in Lower Urinary Tract Infection (LUTI), sponsored by Zhuzhou Qianjin Pharmaceutical Co., Ltd.. Started Feb 2019; status: active.
02
Drugs
Bianju Niaoyan
03
Conditions
Lower Urinary Tract Infection (LUTI)
Beyond the preview
Go deeper on CTR20160351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160351.